150 related articles for article (PubMed ID: 31367591)
1. Monte Carlo Simulation of the Treatment of Uveal Melanoma Using Measured Heterogeneous
Zaragoza FJ; Eichmann M; Flühs D; Wittig A; Sauerwein W; Brualla L
Ocul Oncol Pathol; 2019 Jun; 5(4):276-283. PubMed ID: 31367591
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo Computation of Dose-Volume Histograms in Structures at Risk of an Eye Irradiated with Heterogeneous Ruthenium-106 Plaques.
Zaragoza FJ; Eichmann M; Flühs D; Timmermann B; Brualla L
Ocul Oncol Pathol; 2020 Oct; 6(5):353-359. PubMed ID: 33123529
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo Estimation of Absorbed Dose Distributions Obtained from Heterogeneous
Zaragoza FJ; Eichmann M; Flühs D; Sauerwein W; Brualla L
Ocul Oncol Pathol; 2017 Sep; 3(3):204-209. PubMed ID: 29071271
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric Placement.
Brualla L; Zaragoza FJ; Sauerwein W
Ocul Oncol Pathol; 2014 Oct; 1(1):2-12. PubMed ID: 27175356
[TBL] [Abstract][Full Text] [Related]
5. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
[TBL] [Abstract][Full Text] [Related]
6. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma.
Stålhammar G
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1125-1137. PubMed ID: 37433377
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric Investigation of Six Ru-106 Eye Plaques by EBT3 Radiochromic Films and Monte Carlo Simulation.
Arjmand M; Ghassemi F; Rafiepour P; Zeinali R; Riazi-Esfahani H; Beiki-Ardakani A
J Biomed Phys Eng; 2023 Aug; 13(4):309-316. PubMed ID: 37609514
[TBL] [Abstract][Full Text] [Related]
9. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
10. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
11. Dose Distributions and Treatment Margins in Ocular Brachytherapy with 106Ru Eye Plaques.
Stöckel E; Eichmann M; Flühs D; Sommer H; Biewald E; Bornfeld N; Spaan B; Sauerwein W
Ocul Oncol Pathol; 2018 Sep; 4(2):122-128. PubMed ID: 30320093
[TBL] [Abstract][Full Text] [Related]
12. Absorbed dose distributions from ophthalmic
Hermida-López M; Brualla L
Med Phys; 2018 Apr; 45(4):1699-1707. PubMed ID: 29399810
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
15. Surface dose rate variations in planar and curved geometries of
Bakshi AK; Shrivastava V; Chattaraj A; Samuel K; Palani Selvam T; Sapra BK; Sinharoy P; Banerjee D; Sugilala G; Manohar S; Kaushik CP
Phys Med; 2021 Sep; 89():200-209. PubMed ID: 34399207
[TBL] [Abstract][Full Text] [Related]
16. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
Sánchez-Reyes A; Tello JI; Guix B; Salvat F
Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
[TBL] [Abstract][Full Text] [Related]
18. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
19. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
Mostafa L; Rachid K; Ahmed SM
Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo-based dosimetry of proposed bi-radionuclide (
Mishra S; Selvam TP; Sahoo S; Saxena SK; Kumar Y; Sapra BK
Med Phys; 2024 Jun; ():. PubMed ID: 38935327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
